Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.

Pharmaceutical research - 1 Aug 2017

Weitzel Kristin W, Cavallari Larisa H, Lesko Lawrence J

Abstract excerpt

While recent discoveries have paved the way for the use of genotype-guided prescribing in some clinical environments, significant debate persists among clinicians and researchers about the optimal approach to pharmacogenetic testing in clinical practice. One crucial factor in this debate surrounds the timing and methodology of genotyping, specifically whether genotyping should be performed reactively for targeted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Precision Medicine
Share to Dose-Response Relationship, Drug
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Pharmacogenomic Testing

Source

Open in PubMed Open full text

Identifiers

PMID: 28466392
DOI: 10.1007/s11095-017-2163-x
PMCID: PMC5518315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.PMID 28466392Read ↗

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.Semantic proximity Read ↗

Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.Semantic proximity Read ↗

Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical ImplementationSemantic proximity Read ↗

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.Semantic proximity Read ↗

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.Semantic proximity Read ↗

Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.Semantic proximity Read ↗

Clinical pharmacogenetics: how do we ensure a favorable future for patients?Semantic proximity Read ↗

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A TutorialSemantic proximity Read ↗

Pharmacogenetics in clinical practice: considerations for testing.Semantic proximity Read ↗

Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.Semantic proximity Read ↗

Moving Pharmacogenetics Into Practice: It’s All About the Evidence!Semantic proximity Read ↗

Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.